SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5 | +25.0% | 170 | +11.1% | 0.00% | – |
Q2 2023 | $4 | 0.0% | 153 | +41.7% | 0.00% | – |
Q1 2023 | $4 | -20.0% | 108 | -19.4% | 0.00% | – |
Q4 2022 | $5 | -99.9% | 134 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | +25.0% | 134 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 134 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 134 | -15.7% | 0.00% | – |
Q4 2021 | $5,000 | -28.6% | 159 | -45.0% | 0.00% | – |
Q4 2020 | $7,000 | -12.5% | 289 | +5.1% | 0.00% | – |
Q3 2019 | $8,000 | – | 275 | – | 0.00% | – |
Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $183,000 | -33.9% | 5,500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $277,000 | -27.7% | 5,500 | -14.1% | 0.00% | 0.0% |
Q2 2018 | $383,000 | -35.2% | 6,400 | -83.5% | 0.00% | -66.7% |
Q1 2016 | $591,000 | -79.6% | 38,723 | -82.0% | 0.00% | -81.2% |
Q4 2015 | $2,892,000 | +16.7% | 215,147 | +21.8% | 0.02% | +14.3% |
Q3 2015 | $2,478,000 | +864.2% | 176,635 | +1068.2% | 0.01% | +1300.0% |
Q2 2015 | $257,000 | – | 15,120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |